NICE Key Therapeutic Topics 2018
Posted on:
The 2018 update of NICE ‘medicines optimisation: key therapeutic topics‘ has been published.
The evidence context for all the current topics has been updated in the light of new guidance and important new evidence. 14 topics from 2017 have been retained:
- multimorbidity and polypharmacy
- psychotropic medicines in people with learning disabilities whose behaviour challenges
- safer insulin prescribing
- medicines optimisation in long-term pain
- biosimilar medicines
- acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI
- anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs)
- asthma: medicines safety priorities
- hypnotics
- antipsychotics in people with dementia
- antimicrobial stewardship: prescribing antibiotics
- type 2 diabetes mellitus: medicines optimisation priorities
- non-steroidal anti-inflammatory drugs
- wound care products.
The KTT on lipid modification has been retired and replaced with advice on chemotherapy dose standardisation.